This company has been marked as potentially delisted and may not be actively trading. Ocean Biomedical (OCEA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesOptions ChainShort InterestTrendsBuy This Stock OCEA vs. PTPI, TRVN, ATHX, PBLA, BPTSY, HEPA, VIRX, SYRS, VINC, and UPCShould you be buying Ocean Biomedical stock or one of its competitors? The main competitors of Ocean Biomedical include Petros Pharmaceuticals (PTPI), Trevena (TRVN), Athersys (ATHX), Panbela Therapeutics (PBLA), Biophytis (BPTSY), Hepion Pharmaceuticals (HEPA), Viracta Therapeutics (VIRX), Syros Pharmaceuticals (SYRS), Vincerx Pharma (VINC), and Universe Pharmaceuticals (UPC). These companies are all part of the "pharmaceutical preparations" industry. Ocean Biomedical vs. Its Competitors Petros Pharmaceuticals Trevena Athersys Panbela Therapeutics Biophytis Hepion Pharmaceuticals Viracta Therapeutics Syros Pharmaceuticals Vincerx Pharma Universe Pharmaceuticals Ocean Biomedical (NASDAQ:OCEA) and Petros Pharmaceuticals (NASDAQ:PTPI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. Which has more risk and volatility, OCEA or PTPI? Ocean Biomedical has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Comparatively, Petros Pharmaceuticals has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500. Which has higher earnings & valuation, OCEA or PTPI? Petros Pharmaceuticals has higher revenue and earnings than Ocean Biomedical. Ocean Biomedical is trading at a lower price-to-earnings ratio than Petros Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOcean BiomedicalN/AN/A-$114.47M-$0.94-0.01Petros Pharmaceuticals$5.11M0.20-$8.16M-$60.870.00 Do institutionals and insiders hold more shares of OCEA or PTPI? 24.6% of Ocean Biomedical shares are owned by institutional investors. Comparatively, 12.3% of Petros Pharmaceuticals shares are owned by institutional investors. 73.5% of Ocean Biomedical shares are owned by insiders. Comparatively, 12.3% of Petros Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer OCEA or PTPI? In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Petros Pharmaceuticals'average media sentiment score. Company Overall Sentiment Ocean Biomedical Neutral Petros Pharmaceuticals Neutral Is OCEA or PTPI more profitable? Ocean Biomedical's return on equity of 0.00% beat Petros Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Ocean BiomedicalN/A N/A -931.55% Petros Pharmaceuticals N/A -78.22%-23.50% SummaryOcean Biomedical beats Petros Pharmaceuticals on 5 of the 9 factors compared between the two stocks. Get Ocean Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OCEA and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCEA vs. The Competition Export to ExcelMetricOcean BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$220K$771.23M$5.49B$9.52BDividend YieldN/A4.84%4.73%4.09%P/E Ratio-0.011.3428.7823.81Price / SalesN/A25.68372.2066.04Price / CashN/A19.5635.4557.96Price / Book0.006.768.275.54Net Income-$114.47M-$3.67M$3.25B$259.28M Ocean Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCEAOcean BiomedicalN/A$0.01flatN/A-99.5%$220KN/A-0.01N/ANews CoverageGap DownPTPIPetros PharmaceuticalsN/A$0.03-3.7%N/A-99.7%$904K$5.11M-0.0120Gap DownTRVNTrevena1.5454 of 5 stars$0.91flat$5.00+449.5%-82.5%$873K$443K-0.0240Upcoming EarningsATHXAthersysN/AN/AN/AN/A$833K$146K0.0024PBLAPanbela Therapeutics0.1643 of 5 stars$0.16flatN/A-55.3%$767KN/A0.006Short Interest ↑BPTSYBiophytisN/A$1.81flatN/AN/A$634KN/A0.0030HEPAHepion Pharmaceuticals0.5024 of 5 stars$0.05+0.9%N/A-99.9%$617KN/A-0.0120Gap UpVIRXViracta Therapeutics1.5093 of 5 stars$0.01flat$1.75+17,793.7%N/A$389KN/A-0.0120Short Interest ↑SYRSSyros Pharmaceuticals4.0263 of 5 stars$0.01-50.0%$3.33+33,233.3%-100.0%$268K$386K0.00120Gap DownVINCVincerx Pharma2.5151 of 5 stars$0.05+0.9%$40.00+85,736.9%-99.7%$244KN/A0.0060UPCUniverse PharmaceuticalsN/A$3.97-6.7%N/A-99.8%$170K$19.29M0.00220Gap Down Related Companies and Tools Related Companies PTPI Alternatives TRVN Alternatives ATHX Alternatives PBLA Alternatives BPTSY Alternatives HEPA Alternatives VIRX Alternatives SYRS Alternatives VINC Alternatives UPC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OCEA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocean Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocean Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCEA Stock Alerts